Hodgkin's lymphoma natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 5: Line 5:
The early stage of the Hodgkin's lymphoma is associated with the most favorable prognosis. The 5-year survival rate of patients with Hodgkin's lymphoma varies with the stage of the disease.
The early stage of the Hodgkin's lymphoma is associated with the most favorable prognosis. The 5-year survival rate of patients with Hodgkin's lymphoma varies with the stage of the disease.
==Prognosis==
==Prognosis==
*'''Prognostic factors for early (Stage I and II) Hodgkin's lymphoma'''<ref name=CCS>{{cite web | title = Canadian Cancer Society Hodgkin lymphoma| url =http://www.cancer.ca/en/cancer-information/cancer-type/hodgkin-lymphoma/diagnosis/?region=ab}}</ref>
===Prognostic factors for early (Stage I and II) Hodgkin's lymphoma===<ref name=CCS>{{cite web | title = Canadian Cancer Society Hodgkin lymphoma| url =http://www.cancer.ca/en/cancer-information/cancer-type/hodgkin-lymphoma/diagnosis/?region=ab}}</ref>
* Hodgkin's lymphoma are divided into favorable and unfavorable groups based on prognostic factors.
* Hodgkin's lymphoma are divided into favorable and unfavorable groups based on prognostic factors.
====a. Early favorable Hodgkin's lymphoma====
:*a. Early favorable Hodgkin's lymphoma
* Early favorable Hodgkin's lymphoma means that no factors listed below are present.
::*Early favorable Hodgkin's lymphoma means that no factors listed below are present.
====b. Early unfavorable Hodgkin's lymphoma====
:*Early unfavorable Hodgkin's lymphoma
* Early unfavorable Hodgkin's lymphoma means that one or more of the following factors are present:
::*Early unfavorable Hodgkin's lymphoma means that one or more of the following factors are present:
:* Bulky disease
:* Bulky disease
::* Larger than one-third the width of the chest
::* Larger than one-third the width of the chest

Revision as of 18:57, 23 September 2015

Hodgkin's lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hodgkin's lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray Findings

CT

MRI

Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hodgkin's lymphoma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hodgkin's lymphoma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hodgkin's lymphoma natural history, complications and prognosis

CDC on Hodgkin's lymphoma natural history, complications and prognosis

Hodgkin's lymphoma natural history, complications and prognosis in the news

Blogs on Hodgkin's lymphoma natural history, complications and prognosis

Directions to Hospitals Treating Hodgkin's lymphoma

Risk calculators and risk factors for Hodgkin's lymphoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

The early stage of the Hodgkin's lymphoma is associated with the most favorable prognosis. The 5-year survival rate of patients with Hodgkin's lymphoma varies with the stage of the disease.

Prognosis

===Prognostic factors for early (Stage I and II) Hodgkin's lymphoma===[1]

  • Hodgkin's lymphoma are divided into favorable and unfavorable groups based on prognostic factors.
  • a. Early favorable Hodgkin's lymphoma
  • Early favorable Hodgkin's lymphoma means that no factors listed below are present.
  • Early unfavorable Hodgkin's lymphoma
  • Early unfavorable Hodgkin's lymphoma means that one or more of the following factors are present:
  • Bulky disease
  • Larger than one-third the width of the chest
  • At least 10 cm in its greatest dimension in areas other than the chest
  • Presence of extra nodal disease (in areas other than the lymph nodes)
  • 3 or more areas of lymph node involvement
  • Erythrocyte sedimentation rate (ESR) of 50 mm/h or higher
  • Mixed cellularity Hodgkin's lymphoma
  • Presence of B symptoms
  • Unexplained fever over 38°C
  • Drenching night sweats
  • Unexplained weight loss – loss of more than 10% of original body weight within the last 6 months
  • Prognostic factors in advanced (stage III and IV) Hodgkin's lymphoma[1]
  • The International Prognostic Factors Project (IPFP) has developed an international prognostic score (IPS) based on 7 adverse factors for advanced (stage III and IV) Hodgkin's lymphoma. The factors that are present are combined to give a single score between 0 and 7.

a. Advanced favorable Hodgkin's lymphoma

  • Advanced favorable Hodgkin's lymphoma means that 0 to 3 factors listed below are present.

b. Advanced unfavorable Hodgkin's lymphoma

  • Advanced unfavorable Hodgkin's lymphoma means that 4 or more of the following factors are present:
  • Stage IV disease
  • Age 45 years or older
  • Male sex
  • Albumin level less than 4.0 g/dL
  • Hemoglobin level less than 10.5 g/dL
  • White blood cell (WBC) count at least 15,000/mm3
  • Lymphocyte count less than 600/mm3 or less than 8% of the total WBC count

5-Year Survival

  • Between 2004 and 2010, the 5-year relative survival of patients with Hodgkin's lymphoma was 87.7%.[2]
  • When stratified by age, the 5-year relative survival of patients with Hodgkin's lymphoma was 90.5% and 52.8% for patients <65 and ≥ 65 years of age respectively.[2]
  • The survival of patients with Hodgkin's lymphoma varies with the stage of the disease. Shown below is a table depicting the 5-year relative survival by the stage of Hodgkin's lymphoma:[2]
Stage 5-year relative survival (%), (2004-2010)
All stages 85.3%
Localized 90.8%
Regional 92.1%
Distant 76.2%
Unstaged 80.7%
  • The survival of patients with Hodgkin's lymphoma also varies with the subtype of Hodgkin's lymphoma. Shown below is the 5-year relative survival by the subtype of Hodgkin's lymphoma:[2]
    • Classical Hodgkin's lymphoma: 84.8%
      • Lymphocyte-rich: 87.1%
      • Mixed cellularity: 80%
      • Lymphocyte-depleted: 56.6%
      • Nodular sclerosis: 89.4%
      • Classical Hodgkin's lymphoma not otherwise specified: 75.2%
    • Nodular lymphocyte predominant Hodgkin's lymphoma: 95.3%
  • Shown below is an image depicting the 5-year conditional relative survival (probability of surviving in the next 5-years given the cohort has already survived 0, 1, 3 years) between 1998 and 2010 of Hodgkin's lymphoma by stage at diagnosis according to SEER. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[2]

5-year conditional relative survival (probability of surviving in the next 5-years given the cohort has already survived 0, 1, 3 years) of Hodgkin's lymphoma by stage at diagnosis according to SEER.

References

  1. 1.0 1.1 "Canadian Cancer Society Hodgkin lymphoma".
  2. 2.0 2.1 2.2 2.3 2.4 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.


Template:WikiDoc Sources